Andrew Oxtoby
Direttore/Membro del Consiglio presso Damien Center
Posizioni attive di Andrew Oxtoby
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Damien Center | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Andrew Oxtoby
Precedenti posizioni note di Andrew Oxtoby
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Corporate Officer/Principal | 15/02/2023 | 09/08/2023 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/01/2015 | 01/01/2019 |
Lilly Nederland Holding BV
 Lilly Nederland Holding BV Financial ConglomeratesFinance Part of Eli Lilly & Co., Lilly Nederland Holding BV provides investment services. The company is based in Utrecht, Netherlands. | Corporate Officer/Principal | 01/12/2009 | 01/04/2012 |
| AIMMUNE THERAPEUTICS, INC. | Amministratore Delegato | - | - |
| Corporate Officer/Principal | 22/01/2019 | - | |
| Presidente | - | - |
Formazione di Andrew Oxtoby
| Purdue University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Paesi Bassi | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Chief Executive Officer | 1 |
| President | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| Aziende private | 4 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
| Damien Center | |
Lilly Nederland Holding BV
Lilly Nederland Holding BV Financial ConglomeratesFinance Part of Eli Lilly & Co., Lilly Nederland Holding BV provides investment services. The company is based in Utrecht, Netherlands. | Finance |
- Borsa valori
- Insiders
- Andrew Oxtoby
- Esperienza
